Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring

Helixberg is an independent biotech publication providing concise and insightful briefings on major biotech catalysts and portfolio strategies. We are a team of healthcare professionals who launched this community following long careers in the biotech sector and hedge fund industry. With billions of dollars invested in groundbreaking pharmaceutical research, the biotech industry is moving at lightning speed. Over our careers we were in awe how little some experts in the traditional media understand to be pr ...